VALE MEDTECH CONSULTING LIMITED

The new IPC charger series is the latest innovation in the field of quick-charging. The universal chargers have integrated communication and support all popular communication protocols, such as CAN, I2C, SM, LIN, HDQ. Li-ion rechargeable battery packs from 24 V to 48 V will be automatically detected. Once the E-BUS charger has made contact with the rechargeable battery, an extensive diagnostics procedure is started. The intelligent chargers identify the rechargeable battery voltage, the charge current is adapted and the charge process started. The output power here is up to 300 W. This enables the shortest possible charge times with simultaneous exchange of parameters to be realised with applications such as in drive systems, power tools or medical equipment. With the IPC 300W we are delighted to present a universal charger that can adapt to all lithium ion rechargeable battery systems.

Planning a new development or a redesign of a rechargeable battery or charger? ANSMANN – Your partner from the initial idea through the planning, design, development and manufacturing stages and on to serial manufacturing. Based on your application and the requirements, we can guide you with professional advice for the selection of the correct cells, the capabilities of the necessary protective circuitry, compliance with standards and certification (as early as in the development phase), the first prototypes as STL parts and the first measurements. We can support you through all of the important steps towards your final decision. We can take on the design and manufacturing of the housing parts and the injection and stamping tools required for this. Single-source delivery and manufacturing guarantees optimum interaction between rechargeable battery, BMS and charger. The cells that we use are delivered by renowned manufacturers such as Panasonic, LG, Samsung, Sanyo, A123, Sony, etc.

1) Product Description The Gastrostomy Feeding Tube are indicated for use in patients who require long term feeding, are unable to tolerate oral feeding, who are at low risk for aspration, require gastric decomparession. It is a tube used to supply food and drugs to the stomach. 2) Product Features - Easy and less traumatic to insert due to the soft and compressible internal dome. - Radiopaque dome allows x-ray placement confirmation - Identification of tube obstructions enhanced with translucent tubings - Soft, less traumatic silicone designed for patient comfort

Product Description EarlyTect Colon Cancer Test was approved by the Korea Ministry of Food and Drug Safety through clinical trials at Yonsei Medical Center, Severance Hospital, and Severance Check-up Center for eligible subjects, 585 men and women aged 30 to 80. Clinical trials using fecal DNA demonstrated that CRC can be diagnosed with 90% sensitivity and specificity. EarlyTect Colon Cancer Test is a qualitative real-time PCR test that measures methylated Syndecan-2, a biomarker clinically related to precancerous lesions of CRC, in stool DNA to diagnose colorectal cancer. This product is not intended to confirm colorectal cancer, so if a subject was positive, CRC or precancerous lesions of CRC may exist. Product Standard - Cancer Type: Colorectal Cancer - Subject: Subjects for asymptomatic colorectal cancer screening - Biomarker: SDC2 me The price and transaction conditions are negotiable. Please Request a Quote for the transaction